Benny T. Lee

Array ( [id] => 1391592 [patent_doc_number] => 06541221 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-01 [patent_title] => 'Compositions and methods for non-targeted activation of endogenous genes' [patent_app_type] => B1 [patent_app_number] => 09/481282 [patent_app_country] => US [patent_app_date] => 2000-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 101 [patent_no_of_words] => 62521 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541221.pdf [firstpage_image] =>[orig_patent_app_number] => 09481282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1125536 [patent_doc_number] => 06790442 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-14 [patent_title] => 'Genomic DNA encoding a polypeptide capable of inducing the production of interferon- ' [patent_app_type] => B1 [patent_app_number] => 09/479862 [patent_app_country] => US [patent_app_date] => 2000-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17338 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/790/06790442.pdf [firstpage_image] =>[orig_patent_app_number] => 09479862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1253192 [patent_doc_number] => 06670185 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-30 [patent_title] => 'Compositions and methods for non-targeted activation of endogenous genes' [patent_app_type] => B1 [patent_app_number] => 09/479123 [patent_app_country] => US [patent_app_date] => 2000-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 101 [patent_no_of_words] => 61415 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/670/06670185.pdf [firstpage_image] =>[orig_patent_app_number] => 09479123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288191 [patent_doc_number] => 06268350 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Polynucleotides for inhibiting metastasis and tumor cell growth' [patent_app_type] => 1 [patent_app_number] => 9/479524 [patent_app_country] => US [patent_app_date] => 2000-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 11649 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268350.pdf [firstpage_image] =>[orig_patent_app_number] => 479524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4316090 [patent_doc_number] => 06316690 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Non-mammalian transgenic animal model for cellular proliferative diseases' [patent_app_type] => 1 [patent_app_number] => 9/472661 [patent_app_country] => US [patent_app_date] => 1999-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6917 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316690.pdf [firstpage_image] =>[orig_patent_app_number] => 472661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 968438 [patent_doc_number] => 06939712 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-09-06 [patent_title] => 'Muting gene activity using a transgenic nucleic acid' [patent_app_type] => utility [patent_app_number] => 09/472558 [patent_app_country] => US [patent_app_date] => 1999-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 12996 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/939/06939712.pdf [firstpage_image] =>[orig_patent_app_number] => 09472558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6080769 [patent_doc_number] => 20020081706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'NEGATIVE STRAND RNA VIRAL VECTOR HAVING AUTONOMOUS REPLICATION CAPABILITY' [patent_app_type] => new [patent_app_number] => 09/471840 [patent_app_country] => US [patent_app_date] => 1999-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10052 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20020081706.pdf [firstpage_image] =>[orig_patent_app_number] => 09471840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1043914 [patent_doc_number] => 06867348 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-15 [patent_title] => 'Methods and compositions for screening for angiogenesis modulating compounds' [patent_app_type] => utility [patent_app_number] => 09/465978 [patent_app_country] => US [patent_app_date] => 1999-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 27091 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/867/06867348.pdf [firstpage_image] =>[orig_patent_app_number] => 09465978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1323500 [patent_doc_number] => 06602686 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-05 [patent_title] => 'Compositions and method for non-targeted activation of endogenous genes' [patent_app_type] => B1 [patent_app_number] => 09/455659 [patent_app_country] => US [patent_app_date] => 1999-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 101 [patent_no_of_words] => 62532 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/602/06602686.pdf [firstpage_image] =>[orig_patent_app_number] => 09455659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1516277 [patent_doc_number] => 06500422 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-31 [patent_title] => 'Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (LAG-3)' [patent_app_type] => B2 [patent_app_number] => 09/319147 [patent_app_country] => US [patent_app_date] => 1999-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 6110 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500422.pdf [firstpage_image] =>[orig_patent_app_number] => 09319147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1366007 [patent_doc_number] => 06566128 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'Adenovirus vectors generated from helper viruses and helper-dependent vectors' [patent_app_type] => B1 [patent_app_number] => 09/440809 [patent_app_country] => US [patent_app_date] => 1999-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 19 [patent_no_of_words] => 9362 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566128.pdf [firstpage_image] =>[orig_patent_app_number] => 09440809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1335166 [patent_doc_number] => 06593105 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-15 [patent_title] => 'Prion propagation inhibition by dominant-negative prion protein mutants' [patent_app_type] => B1 [patent_app_number] => 09/367572 [patent_app_country] => US [patent_app_date] => 1999-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 4212 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593105.pdf [firstpage_image] =>[orig_patent_app_number] => 09367572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7645388 [patent_doc_number] => 06472583 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'Plasmid-based mutation detection system in transgenic fish' [patent_app_type] => B1 [patent_app_number] => 09/427218 [patent_app_country] => US [patent_app_date] => 1999-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12344 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/472/06472583.pdf [firstpage_image] =>[orig_patent_app_number] => 09427218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4255521 [patent_doc_number] => 06207878 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Sarcospan-deficient mouse as a model for clinical disorders associated with sarcospan mutations' [patent_app_type] => 1 [patent_app_number] => 9/422762 [patent_app_country] => US [patent_app_date] => 1999-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10262 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207878.pdf [firstpage_image] =>[orig_patent_app_number] => 422762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1288343 [patent_doc_number] => 06632663 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-14 [patent_title] => 'DNA immunization against chlamydia infection' [patent_app_type] => B1 [patent_app_number] => 09/401780 [patent_app_country] => US [patent_app_date] => 1999-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 4655 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/632/06632663.pdf [firstpage_image] =>[orig_patent_app_number] => 09401780 [rel_patent_id] =>[rel_patent_doc_number] =>)